Welcome to Merial US


HEARTGARD (ivermectin)
HEARTGARD Plus (ivermectin/pyrantel)

Products
RECOMBITEK®

TARGETED PREVENTION. PURE PROTECTION
Logo

RECOMBITEK® Lyme
RECOMBITEK® Distemper
RECOMBITEK® Canine Parvo
RECOMBITEK® Corona MLV

 
RECOMBITEK® Lyme
Targeted Protection through Recombinant Technology


By using only pure outer surface protein A (OspA), RECOMBITEK Lyme provides unsurpassed efficacy without the potentially harmful flagellan protein1. Plus, RECOMBITEK Lyme contains no chemical adjuvants, thus eliminating the potential risk typically associated with adjuvants.
  • Recombinant subunit technology uses only a pure non-adjuvanted protein to stimulate immunity
  • Shown in studies to completely block transmission of Lyme disease spirochete2
  • Not a whole cell bacteria

Back to Top

 
RECOMBITEK® rDistemper
Recombinant Vectored Vaccine for Targeted Protection


Through the advanced technology of Type 3 recombinant vaccine manufacturing, RECOMBITEK rDistemper offers safe, proven, efficacious distemper protection to your canine patients, without the potential risks associated with modified-live distemper vaccines.
  • Contains DNA sequence of both the HA (hemagglutinin) and F (fusion membrane protein) antigens
  • Outstanding efficacy even in the face of maternal antibodies
  • Used throughout North and South America including highly endemic areas of Mexico and Brazil

Back to Top

 
RECOMBITEK® Canine Parvo
Powerful Protection for Puppies


RECOMBITEK Canine Parvo helps close the window of vulnerability to canine parvovirus, even in puppies born with high levels of maternal antibodies. While declining levels of maternal antibodies may not protect puppies from viral infection, they may interfere with the effectiveness of a vaccine. RECOMBITEK Canine Parvo breaks through maternal antibodies to provide safe, proven, powerful protection.
  • Proven protection against canine parvovirus (CPV) by 12 weeks of age
  • High-titer, low-passage profile helps break through maternal antibodies
  • Protects against CPV2a and CPV2b
  • Non-immunosuppressive with no reversion to virulence
  • Millions of doses sold throughout North and South America3

Back to Top

 
RECOMBITEK® Corona MLV
The Only Modified-Live Corona Vaccine Available


RECOMBITEK Corona MLV is the only modified-live, canine-origin coronavirus available today, providing early rapid protection against canine coronavirus (CCV).
  • Prevents intestinal damage4
  • Prevents shedding of virulent virus4
  • No virus isolated in over 90% of small intestine samples4
  • Rapid, early protection against clinical and asymptomatic forms of CCV4
  • Proven protection in the face of maternal antibodies

TECHNICAL BULLETINS

Lyme Disease

The Life Cycle of Ticks


CLICK HERE FOR PRODUCT MSDS


FOOTNOTES
1Wormser GP. Prospects for a vaccine to prevent Lyme disease in humans. Clinical Infectious Disease 1995;21:1267-74.
2Conlon JA, Mather TN, Tanner P, Gallo G. Efficacy of a nonadjuvanted, outer surface protein I, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi. Veterinary Therapeutics. 2000;1(2):96-107.
3Data on file at Merial.
4Pardo MC, Mackowiak M. Efficacy of a new canine-origin, modified-live virus vaccine against canine coronavirus. Canine Practice 1999;24:6-8.
 
 
Welcome, Pet Owner
 
 
 
 
     
     
     
     
   
   
   
City
Zip 
 
   
 
     
 
   
 
     
 
©2014 Merial Limited, Duluth, GA. All rights reserved. USMERREMSVS2013 (6/2013).
Contact | Privacy | Legal Notification | Visit the Corporate Merial.com